Is Halozyme Therapeutics, Inc. technically bullish or bearish?

Oct 05 2025 11:54 AM IST
share
Share Via
As of October 3, 2025, Halozyme Therapeutics, Inc. has a mildly bullish technical trend, supported by bullish MACD and Bollinger Bands, despite underperforming the S&P 500 recently while outperforming it year-to-date.
As of 3 October 2025, the technical trend for Halozyme Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly and monthly MACD indicators are bullish, while the Bollinger Bands show a mildly bullish stance in both time frames. The daily moving averages are also mildly bullish. However, the Dow Theory indicates a mildly bearish outlook on the weekly chart, contrasting with the bullish monthly view.

In terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of -6.47% and -7.81% respectively, while it has outperformed the index year-to-date with a return of 44.28% compared to 14.18% for the S&P 500. Overall, the current technical stance is mildly bullish, driven primarily by the MACD and Bollinger Bands.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News